On July 10, Gilead Sciences fell 3.04% in regular trading, trading at $130.705 USD/share, with Turnover of $244 million.
Within the Biotechnology sector where Gilead Sciences belongs, stocks declined broadly. Among individual stocks, AbbVie down 1.36%, Moderna down 10.21%, Ionis Pharmaceuticals down 8.73%, Alnylam Pharmaceuticals down 4.24%, BridgeBio Pharma down 3.32%.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)